Calcitonin gene-related peptide (CGRP) inhibitors are a migraine prophylaxis treatment for patients who have not responded to conventional migraine therapies. However, it is unclear whether trying...
RINVOQ is indicated for the treatment of adult patients with giant cell arteritis (GCA). RINVOQ is used in combination with corticosteroids and as monotherapy following discontinuation of corticosteroids.
Omvoh (mirikizumab) is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response, loss of response, or were intolerant to either conventional therapy or a biologic treatment.
Multiple sclerosis (MS) is a chronic autoimmune disease with the following clinical manifestations: demyelination, inflammation, neuronal loss, and gliosis (scarring). Relapsing-remitting multiple...
Multiple Sclerosis, relapsing
Monotherapy in the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who have hemolytic anemia.
For the treatment of adult
patients with moderate to severe hidradenitis suppurativa
The treatment of adult patients with moderately to severely active ulcerative colitis.
Columvi (glofitamab for injection) in combination with gemcitabine and oxaliplatin for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma not otherwise specified (DLBCL NOS) who are not candidates for autologous stem cell transplant (ASCT).